Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hospitals, Pediatric | 11 | 2024 | 1860 | 1.840 |
Why?
|
Neonatal Abstinence Syndrome | 4 | 2024 | 108 | 1.620 |
Why?
|
Bell Palsy | 2 | 2021 | 39 | 1.460 |
Why?
|
Parenteral Nutrition, Home | 3 | 2018 | 39 | 1.340 |
Why?
|
International Normalized Ratio | 12 | 2016 | 382 | 1.230 |
Why?
|
Catheter-Related Infections | 4 | 2018 | 273 | 1.110 |
Why?
|
Homosexuality, Female | 6 | 2019 | 171 | 1.090 |
Why?
|
Bisexuality | 7 | 2019 | 294 | 1.070 |
Why?
|
Warfarin | 15 | 2016 | 1483 | 1.060 |
Why?
|
Accidents, Occupational | 4 | 2012 | 249 | 0.970 |
Why?
|
Respiratory Syncytial Virus, Human | 2 | 2024 | 150 | 0.970 |
Why?
|
Anticoagulants | 19 | 2016 | 4812 | 0.860 |
Why?
|
Quality Indicators, Health Care | 4 | 2021 | 1792 | 0.840 |
Why?
|
Body Fluids | 1 | 2024 | 320 | 0.790 |
Why?
|
Colorectal Neoplasms | 9 | 2023 | 6935 | 0.770 |
Why?
|
Natural Language Processing | 4 | 2024 | 1162 | 0.710 |
Why?
|
Naloxone | 2 | 2013 | 370 | 0.690 |
Why?
|
Hospitals, Public | 1 | 2021 | 202 | 0.690 |
Why?
|
Vaccines | 3 | 2022 | 844 | 0.660 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2024 | 366 | 0.660 |
Why?
|
Malpractice | 2 | 2023 | 556 | 0.630 |
Why?
|
Sexual Behavior | 10 | 2021 | 2180 | 0.610 |
Why?
|
Narcotic Antagonists | 2 | 2013 | 585 | 0.590 |
Why?
|
Hospital Administrators | 1 | 2018 | 57 | 0.590 |
Why?
|
Drug Interactions | 3 | 2020 | 1416 | 0.580 |
Why?
|
Occupational Diseases | 3 | 2010 | 1490 | 0.550 |
Why?
|
Heterosexuality | 4 | 2023 | 309 | 0.540 |
Why?
|
Workers' Compensation | 5 | 2014 | 150 | 0.530 |
Why?
|
Health Services | 1 | 2021 | 752 | 0.530 |
Why?
|
Risk Management | 1 | 2019 | 558 | 0.530 |
Why?
|
Survivors | 8 | 2022 | 2371 | 0.520 |
Why?
|
Patient Readmission | 5 | 2022 | 3270 | 0.500 |
Why?
|
Hospital Information Systems | 1 | 2018 | 394 | 0.500 |
Why?
|
Hospitalization | 9 | 2024 | 10723 | 0.490 |
Why?
|
Community-Acquired Infections | 1 | 2018 | 469 | 0.470 |
Why?
|
Infant, Newborn | 27 | 2024 | 26198 | 0.470 |
Why?
|
BCG Vaccine | 3 | 2022 | 369 | 0.460 |
Why?
|
Quality Improvement | 10 | 2023 | 3801 | 0.460 |
Why?
|
Population Surveillance | 9 | 2024 | 2598 | 0.450 |
Why?
|
Humans | 148 | 2024 | 761504 | 0.440 |
Why?
|
Drug Monitoring | 3 | 2015 | 962 | 0.430 |
Why?
|
Medical Order Entry Systems | 1 | 2018 | 521 | 0.420 |
Why?
|
Inpatients | 2 | 2023 | 2548 | 0.420 |
Why?
|
Medication Errors | 2 | 2018 | 783 | 0.420 |
Why?
|
Data Collection | 5 | 2014 | 3322 | 0.420 |
Why?
|
Patient Discharge | 2 | 2022 | 3443 | 0.390 |
Why?
|
United States | 37 | 2024 | 72334 | 0.390 |
Why?
|
Space-Time Clustering | 2 | 2009 | 45 | 0.390 |
Why?
|
Hospital Costs | 1 | 2018 | 947 | 0.390 |
Why?
|
Adjuvants, Immunologic | 5 | 2024 | 1036 | 0.380 |
Why?
|
Opioid-Related Disorders | 3 | 2023 | 2164 | 0.380 |
Why?
|
Adenosine Deaminase | 2 | 2024 | 251 | 0.360 |
Why?
|
Toll-Like Receptor 8 | 2 | 2024 | 99 | 0.360 |
Why?
|
Health Education | 2 | 2017 | 1052 | 0.350 |
Why?
|
Homosexuality | 1 | 2011 | 267 | 0.350 |
Why?
|
Narcotics | 1 | 2012 | 336 | 0.350 |
Why?
|
Methadone | 1 | 2012 | 321 | 0.340 |
Why?
|
Atrial Fibrillation | 10 | 2016 | 5127 | 0.340 |
Why?
|
Infant | 26 | 2024 | 36192 | 0.340 |
Why?
|
Toll-Like Receptor 7 | 2 | 2024 | 177 | 0.340 |
Why?
|
Disease Outbreaks | 6 | 2014 | 1749 | 0.340 |
Why?
|
Child | 34 | 2024 | 80153 | 0.330 |
Why?
|
Female | 94 | 2024 | 392644 | 0.330 |
Why?
|
Bacteremia | 4 | 2021 | 979 | 0.330 |
Why?
|
Turkey | 2 | 2021 | 254 | 0.320 |
Why?
|
Databases, Factual | 6 | 2018 | 7967 | 0.310 |
Why?
|
Blood Coagulation | 6 | 2016 | 1154 | 0.310 |
Why?
|
Homosexuality, Male | 2 | 2014 | 1334 | 0.310 |
Why?
|
Hospitals | 5 | 2023 | 3882 | 0.300 |
Why?
|
Male | 82 | 2024 | 360804 | 0.300 |
Why?
|
United States Department of Veterans Affairs | 7 | 2016 | 928 | 0.300 |
Why?
|
Topography, Medical | 1 | 2007 | 37 | 0.300 |
Why?
|
Length of Stay | 5 | 2024 | 6425 | 0.300 |
Why?
|
Cytokines | 9 | 2024 | 7396 | 0.300 |
Why?
|
Communication | 3 | 2020 | 3873 | 0.300 |
Why?
|
Hemorrhage | 9 | 2015 | 3424 | 0.290 |
Why?
|
Judgment | 1 | 2010 | 273 | 0.290 |
Why?
|
Quality Assurance, Health Care | 1 | 2018 | 2169 | 0.290 |
Why?
|
Analgesics, Opioid | 5 | 2024 | 3808 | 0.280 |
Why?
|
Child, Preschool | 20 | 2024 | 42230 | 0.260 |
Why?
|
Health Surveys | 2 | 2014 | 4061 | 0.260 |
Why?
|
Chemokines | 4 | 2024 | 960 | 0.250 |
Why?
|
Sentinel Surveillance | 1 | 2007 | 291 | 0.250 |
Why?
|
Electronic Health Records | 3 | 2022 | 4811 | 0.250 |
Why?
|
Health Care Costs | 1 | 2018 | 3242 | 0.250 |
Why?
|
Epidemiologic Measurements | 1 | 2004 | 23 | 0.240 |
Why?
|
Geographic Information Systems | 2 | 2014 | 281 | 0.240 |
Why?
|
Research Design | 3 | 2016 | 6180 | 0.240 |
Why?
|
Wounds and Injuries | 3 | 2020 | 2491 | 0.240 |
Why?
|
Health Behavior | 2 | 2015 | 2643 | 0.230 |
Why?
|
Delivery of Health Care | 2 | 2019 | 5336 | 0.230 |
Why?
|
Fetal Blood | 3 | 2021 | 1347 | 0.230 |
Why?
|
Quality of Life | 6 | 2022 | 13367 | 0.230 |
Why?
|
Aged | 44 | 2024 | 169289 | 0.230 |
Why?
|
Monocytes | 3 | 2024 | 2570 | 0.220 |
Why?
|
Down Syndrome | 3 | 2017 | 901 | 0.220 |
Why?
|
Immunity, Innate | 5 | 2024 | 3065 | 0.220 |
Why?
|
Health Services Accessibility | 2 | 2019 | 5440 | 0.220 |
Why?
|
Massachusetts | 10 | 2018 | 8830 | 0.220 |
Why?
|
Minority Groups | 4 | 2015 | 1203 | 0.210 |
Why?
|
Gambia | 4 | 2024 | 104 | 0.210 |
Why?
|
Patient Education as Topic | 3 | 2019 | 2319 | 0.210 |
Why?
|
Data Interpretation, Statistical | 5 | 2013 | 2691 | 0.200 |
Why?
|
Vaccines, Synthetic | 2 | 2022 | 616 | 0.200 |
Why?
|
Pressure Ulcer | 1 | 2023 | 157 | 0.200 |
Why?
|
Health Status Disparities | 1 | 2014 | 1852 | 0.200 |
Why?
|
Physicians | 2 | 2019 | 4591 | 0.200 |
Why?
|
Leukocytes, Mononuclear | 3 | 2024 | 1844 | 0.200 |
Why?
|
Aluminum Hydroxide | 1 | 2022 | 54 | 0.200 |
Why?
|
Streptococcal Infections | 2 | 2018 | 617 | 0.200 |
Why?
|
United States Agency for Healthcare Research and Quality | 1 | 2021 | 86 | 0.200 |
Why?
|
Neutrophils | 2 | 2024 | 3767 | 0.190 |
Why?
|
Insurance | 1 | 2023 | 113 | 0.190 |
Why?
|
Adolescent | 28 | 2024 | 88319 | 0.190 |
Why?
|
Retrospective Studies | 22 | 2024 | 80636 | 0.190 |
Why?
|
Cluster Analysis | 2 | 2005 | 2707 | 0.190 |
Why?
|
Behavioral Risk Factor Surveillance System | 2 | 2020 | 209 | 0.190 |
Why?
|
Influenza, Human | 3 | 2023 | 1521 | 0.190 |
Why?
|
Breast Neoplasms | 7 | 2018 | 21012 | 0.190 |
Why?
|
Electronics | 1 | 2022 | 318 | 0.180 |
Why?
|
Incidence | 9 | 2023 | 21353 | 0.180 |
Why?
|
Sports Equipment | 1 | 2020 | 27 | 0.180 |
Why?
|
Time | 1 | 2022 | 546 | 0.180 |
Why?
|
Accidents, Home | 1 | 2020 | 71 | 0.180 |
Why?
|
Middle Aged | 45 | 2024 | 220895 | 0.180 |
Why?
|
Telemedicine | 1 | 2018 | 3051 | 0.180 |
Why?
|
Survival Rate | 2 | 2013 | 12725 | 0.180 |
Why?
|
Acyclovir | 1 | 2021 | 268 | 0.180 |
Why?
|
Iatrogenic Disease | 1 | 2023 | 539 | 0.180 |
Why?
|
Defensive Medicine | 1 | 2019 | 47 | 0.170 |
Why?
|
Venous Thromboembolism | 3 | 2014 | 1866 | 0.170 |
Why?
|
Registries | 6 | 2023 | 8224 | 0.170 |
Why?
|
Acute-Phase Proteins | 1 | 2020 | 250 | 0.170 |
Why?
|
Models, Statistical | 6 | 2017 | 5079 | 0.170 |
Why?
|
Young Adult | 22 | 2024 | 59243 | 0.160 |
Why?
|
Papua New Guinea | 3 | 2024 | 46 | 0.160 |
Why?
|
Anthropometry | 1 | 2023 | 1349 | 0.160 |
Why?
|
Adult | 41 | 2024 | 221177 | 0.160 |
Why?
|
Toll-Like Receptors | 2 | 2019 | 589 | 0.160 |
Why?
|
Troponin | 1 | 2022 | 502 | 0.160 |
Why?
|
Creatinine | 2 | 2022 | 1899 | 0.160 |
Why?
|
Microbial Viability | 1 | 2020 | 238 | 0.160 |
Why?
|
Computer Simulation | 5 | 2013 | 6240 | 0.150 |
Why?
|
Chorioamnionitis | 1 | 2019 | 156 | 0.150 |
Why?
|
Hemophilia A | 1 | 2021 | 360 | 0.150 |
Why?
|
Liability, Legal | 1 | 2019 | 210 | 0.150 |
Why?
|
Cathelicidins | 1 | 2018 | 80 | 0.150 |
Why?
|
Thromboembolism | 2 | 2015 | 995 | 0.150 |
Why?
|
Child, Hospitalized | 2 | 2023 | 182 | 0.150 |
Why?
|
RNA, Bacterial | 1 | 2020 | 393 | 0.150 |
Why?
|
Child Development | 2 | 2020 | 2306 | 0.150 |
Why?
|
Disabled Persons | 1 | 2008 | 1225 | 0.150 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2024 | 1651 | 0.150 |
Why?
|
Plasma | 1 | 2021 | 586 | 0.150 |
Why?
|
Italy | 1 | 2019 | 842 | 0.150 |
Why?
|
Complement System Proteins | 1 | 2020 | 736 | 0.140 |
Why?
|
Calcinosis | 2 | 2017 | 1469 | 0.140 |
Why?
|
Breast Diseases | 1 | 2020 | 442 | 0.140 |
Why?
|
Intensive Care Units, Neonatal | 3 | 2024 | 846 | 0.140 |
Why?
|
Immunoglobulins | 1 | 2020 | 853 | 0.140 |
Why?
|
Cross Infection | 2 | 2017 | 1422 | 0.140 |
Why?
|
Mannose-Binding Lectin | 1 | 2018 | 145 | 0.140 |
Why?
|
Malnutrition | 1 | 2023 | 645 | 0.140 |
Why?
|
Reminder Systems | 1 | 2020 | 388 | 0.140 |
Why?
|
Cytomegalovirus Infections | 1 | 2023 | 831 | 0.140 |
Why?
|
Abscess | 1 | 2020 | 606 | 0.140 |
Why?
|
Epidemiologic Methods | 2 | 2013 | 1336 | 0.140 |
Why?
|
Family | 2 | 2018 | 3194 | 0.140 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2013 | 2790 | 0.140 |
Why?
|
Neoplasms | 4 | 2020 | 22170 | 0.140 |
Why?
|
Stroke | 6 | 2016 | 9757 | 0.140 |
Why?
|
Lymphocytes | 1 | 2024 | 2612 | 0.140 |
Why?
|
HIV Seropositivity | 1 | 2022 | 960 | 0.130 |
Why?
|
Eustachian Tube | 1 | 2017 | 99 | 0.130 |
Why?
|
Quality of Health Care | 3 | 2020 | 4330 | 0.130 |
Why?
|
Perception | 2 | 2020 | 1197 | 0.130 |
Why?
|
Pharyngitis | 1 | 2018 | 219 | 0.130 |
Why?
|
Severity of Illness Index | 3 | 2024 | 15842 | 0.130 |
Why?
|
Computer Security | 1 | 2018 | 261 | 0.130 |
Why?
|
Breast Feeding | 1 | 2024 | 1359 | 0.130 |
Why?
|
Videoconferencing | 1 | 2018 | 203 | 0.130 |
Why?
|
Employee Performance Appraisal | 1 | 2016 | 86 | 0.130 |
Why?
|
Administration, Oral | 7 | 2011 | 4021 | 0.130 |
Why?
|
Ear Diseases | 1 | 2017 | 180 | 0.130 |
Why?
|
HIV Infections | 5 | 2023 | 17351 | 0.130 |
Why?
|
Time Factors | 10 | 2021 | 39967 | 0.130 |
Why?
|
Parents | 3 | 2017 | 3563 | 0.130 |
Why?
|
Cyclic AMP | 1 | 2019 | 1463 | 0.130 |
Why?
|
Vaccines, Conjugate | 1 | 2017 | 328 | 0.120 |
Why?
|
Mandibular Fractures | 1 | 2016 | 76 | 0.120 |
Why?
|
Medication Reconciliation | 1 | 2017 | 153 | 0.120 |
Why?
|
Incidental Findings | 2 | 2017 | 697 | 0.120 |
Why?
|
Immune System | 1 | 2020 | 796 | 0.120 |
Why?
|
Phenotype | 2 | 2024 | 16591 | 0.120 |
Why?
|
RNA, Messenger | 4 | 2022 | 12795 | 0.120 |
Why?
|
Healthcare Disparities | 3 | 2019 | 3358 | 0.120 |
Why?
|
Body Weight | 2 | 2023 | 4618 | 0.120 |
Why?
|
Parotid Diseases | 1 | 2014 | 49 | 0.120 |
Why?
|
Myocarditis | 1 | 2022 | 788 | 0.120 |
Why?
|
Colony Count, Microbial | 1 | 2015 | 330 | 0.120 |
Why?
|
Prospective Studies | 11 | 2024 | 54425 | 0.120 |
Why?
|
Short Bowel Syndrome | 1 | 2018 | 353 | 0.120 |
Why?
|
Health Care Surveys | 2 | 2020 | 2426 | 0.120 |
Why?
|
Aged, 80 and over | 17 | 2024 | 58976 | 0.120 |
Why?
|
Evaluation Studies as Topic | 1 | 2016 | 1624 | 0.120 |
Why?
|
Risk Factors | 14 | 2022 | 74206 | 0.110 |
Why?
|
Mandatory Reporting | 1 | 2015 | 123 | 0.110 |
Why?
|
Maternal Health Services | 1 | 2019 | 461 | 0.110 |
Why?
|
Alkaline Phosphatase | 1 | 2017 | 864 | 0.110 |
Why?
|
RNA, Viral | 1 | 2022 | 2846 | 0.110 |
Why?
|
Patient Satisfaction | 2 | 2021 | 3461 | 0.110 |
Why?
|
Human Rights Abuses | 1 | 2013 | 31 | 0.110 |
Why?
|
Vaccination | 2 | 2024 | 3384 | 0.110 |
Why?
|
Thyroid Diseases | 1 | 2017 | 386 | 0.110 |
Why?
|
Intestinal Diseases | 1 | 2018 | 504 | 0.110 |
Why?
|
Morphine | 1 | 2018 | 657 | 0.110 |
Why?
|
Parenteral Nutrition | 1 | 2018 | 659 | 0.110 |
Why?
|
Influenza Vaccines | 1 | 2021 | 768 | 0.110 |
Why?
|
Practice Guidelines as Topic | 3 | 2024 | 7390 | 0.110 |
Why?
|
Pneumococcal Vaccines | 1 | 2017 | 397 | 0.110 |
Why?
|
Catheterization, Central Venous | 1 | 2018 | 527 | 0.110 |
Why?
|
International Cooperation | 1 | 2019 | 1422 | 0.110 |
Why?
|
Birth Weight | 1 | 2021 | 2103 | 0.110 |
Why?
|
Lipopolysaccharides | 2 | 2019 | 2206 | 0.110 |
Why?
|
Triiodobenzoic Acids | 2 | 2010 | 123 | 0.110 |
Why?
|
Respiration, Artificial | 1 | 2024 | 2628 | 0.110 |
Why?
|
Amputation, Traumatic | 1 | 2014 | 135 | 0.100 |
Why?
|
Pediatric Nursing | 1 | 2014 | 104 | 0.100 |
Why?
|
Infant, Premature | 2 | 2019 | 2107 | 0.100 |
Why?
|
Genetic Counseling | 1 | 2016 | 627 | 0.100 |
Why?
|
B-Lymphocytes | 2 | 2024 | 4758 | 0.100 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 1664 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2020 | 1390 | 0.100 |
Why?
|
Liver Cirrhosis | 2 | 2013 | 1935 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 5 | 2017 | 20570 | 0.100 |
Why?
|
Pyrimidines | 1 | 2024 | 3028 | 0.100 |
Why?
|
Hypothyroidism | 1 | 2017 | 668 | 0.100 |
Why?
|
Prenatal Care | 1 | 2019 | 1139 | 0.100 |
Why?
|
Insurance, Disability | 1 | 2012 | 27 | 0.100 |
Why?
|
Hospitals, Veterans | 2 | 2011 | 395 | 0.100 |
Why?
|
Virus Diseases | 1 | 2018 | 718 | 0.100 |
Why?
|
Health Status | 4 | 2015 | 4077 | 0.100 |
Why?
|
Harm Reduction | 1 | 2013 | 144 | 0.100 |
Why?
|
Social Security | 1 | 2012 | 101 | 0.100 |
Why?
|
Population Dynamics | 1 | 2013 | 307 | 0.100 |
Why?
|
Allied Health Personnel | 1 | 2013 | 155 | 0.100 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2019 | 942 | 0.100 |
Why?
|
Leukocytes | 1 | 2019 | 2026 | 0.090 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2012 | 410 | 0.090 |
Why?
|
Pharyngeal Muscles | 1 | 2011 | 81 | 0.090 |
Why?
|
Disease Progression | 3 | 2024 | 13506 | 0.090 |
Why?
|
Child Health Services | 1 | 2016 | 646 | 0.090 |
Why?
|
Pilot Projects | 5 | 2023 | 8631 | 0.090 |
Why?
|
Administration, Intranasal | 1 | 2012 | 477 | 0.090 |
Why?
|
Prevalence | 6 | 2020 | 15732 | 0.090 |
Why?
|
Homicide | 1 | 2013 | 294 | 0.090 |
Why?
|
Risk Adjustment | 2 | 2014 | 600 | 0.090 |
Why?
|
Inflammation Mediators | 1 | 2019 | 1886 | 0.090 |
Why?
|
Stomatitis | 1 | 2013 | 271 | 0.090 |
Why?
|
Heart Defects, Congenital | 2 | 2018 | 4671 | 0.090 |
Why?
|
Proteome | 1 | 2020 | 1862 | 0.090 |
Why?
|
Multicenter Studies as Topic | 1 | 2015 | 1702 | 0.090 |
Why?
|
Resilience, Psychological | 1 | 2018 | 788 | 0.090 |
Why?
|
DNA Methylation | 1 | 2024 | 4398 | 0.090 |
Why?
|
Reproducibility of Results | 8 | 2015 | 20098 | 0.090 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2011 | 189 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2024 | 15936 | 0.090 |
Why?
|
Reference Values | 3 | 2012 | 4920 | 0.090 |
Why?
|
Tonsillar Neoplasms | 1 | 2010 | 50 | 0.090 |
Why?
|
Psychosocial Deprivation | 1 | 2010 | 99 | 0.090 |
Why?
|
Radiotherapy, Conformal | 1 | 2013 | 548 | 0.090 |
Why?
|
Dendritic Cells | 1 | 2021 | 2747 | 0.090 |
Why?
|
California | 1 | 2014 | 1429 | 0.090 |
Why?
|
Age Factors | 7 | 2024 | 18395 | 0.080 |
Why?
|
Synovitis | 1 | 2011 | 217 | 0.080 |
Why?
|
Palatine Tonsil | 1 | 2010 | 193 | 0.080 |
Why?
|
Operating Rooms | 1 | 2016 | 789 | 0.080 |
Why?
|
Rural Population | 2 | 2019 | 2285 | 0.080 |
Why?
|
Lung Neoplasms | 1 | 2014 | 13380 | 0.080 |
Why?
|
Cohort Studies | 7 | 2023 | 41487 | 0.080 |
Why?
|
Pandemics | 4 | 2022 | 8654 | 0.080 |
Why?
|
Minnesota | 1 | 2010 | 338 | 0.080 |
Why?
|
Diarrhea | 1 | 2016 | 1318 | 0.080 |
Why?
|
Tuberculosis | 1 | 2022 | 2017 | 0.080 |
Why?
|
Checklist | 1 | 2016 | 827 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2013 | 3357 | 0.080 |
Why?
|
Decision Support Systems, Clinical | 1 | 2018 | 1175 | 0.080 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2012 | 437 | 0.080 |
Why?
|
Celiac Disease | 1 | 2016 | 821 | 0.080 |
Why?
|
Nipples | 1 | 2010 | 229 | 0.080 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39106 | 0.080 |
Why?
|
Respiratory Tract Infections | 1 | 2016 | 1010 | 0.080 |
Why?
|
Opiate Substitution Treatment | 1 | 2012 | 444 | 0.080 |
Why?
|
Amyloidosis, Familial | 1 | 2007 | 16 | 0.070 |
Why?
|
AIDS Serodiagnosis | 1 | 2009 | 220 | 0.070 |
Why?
|
Tobacco Smoke Pollution | 1 | 2014 | 819 | 0.070 |
Why?
|
Pediatrics | 3 | 2020 | 3589 | 0.070 |
Why?
|
Ambulatory Care Facilities | 2 | 2011 | 935 | 0.070 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2012 | 625 | 0.070 |
Why?
|
Medical Errors | 1 | 2016 | 1263 | 0.070 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2013 | 491 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2018 | 2220 | 0.070 |
Why?
|
Parental Notification | 1 | 2007 | 12 | 0.070 |
Why?
|
Proteomics | 4 | 2022 | 3849 | 0.070 |
Why?
|
Xylitol | 1 | 2007 | 23 | 0.070 |
Why?
|
Veterans Health | 3 | 2015 | 215 | 0.070 |
Why?
|
Violence | 1 | 2013 | 936 | 0.070 |
Why?
|
Rhode Island | 1 | 2008 | 351 | 0.070 |
Why?
|
Critical Care | 2 | 2017 | 2696 | 0.070 |
Why?
|
Anti-Bacterial Agents | 4 | 2021 | 7407 | 0.070 |
Why?
|
Genetic Linkage | 1 | 2012 | 2341 | 0.070 |
Why?
|
Nepal | 2 | 2019 | 305 | 0.070 |
Why?
|
Curriculum | 2 | 2013 | 3743 | 0.070 |
Why?
|
Immunoglobulin Light Chains | 1 | 2007 | 285 | 0.070 |
Why?
|
Censuses | 1 | 2008 | 202 | 0.070 |
Why?
|
Health Personnel | 1 | 2020 | 3335 | 0.070 |
Why?
|
Immunoglobulin Variable Region | 1 | 2007 | 419 | 0.070 |
Why?
|
Chronic Disease | 3 | 2017 | 9318 | 0.070 |
Why?
|
Medical Record Linkage | 1 | 2008 | 285 | 0.070 |
Why?
|
Sexuality | 1 | 2008 | 180 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2013 | 4026 | 0.070 |
Why?
|
Eligibility Determination | 1 | 2010 | 421 | 0.070 |
Why?
|
Maps as Topic | 1 | 2005 | 18 | 0.070 |
Why?
|
Selection Bias | 1 | 2008 | 359 | 0.060 |
Why?
|
Body Mass Index | 1 | 2023 | 12953 | 0.060 |
Why?
|
Counseling | 1 | 2014 | 1547 | 0.060 |
Why?
|
Radiation Injuries | 1 | 2013 | 1189 | 0.060 |
Why?
|
Demography | 2 | 2015 | 1648 | 0.060 |
Why?
|
Leukemia | 1 | 2014 | 1522 | 0.060 |
Why?
|
Prescription Drugs | 1 | 2013 | 631 | 0.060 |
Why?
|
Liver Diseases | 1 | 2014 | 1298 | 0.060 |
Why?
|
Image Enhancement | 2 | 2013 | 2885 | 0.060 |
Why?
|
Deglutition Disorders | 1 | 2011 | 625 | 0.060 |
Why?
|
Spouses | 1 | 2008 | 283 | 0.060 |
Why?
|
Evidence-Based Practice | 1 | 2009 | 495 | 0.060 |
Why?
|
Monitoring, Physiologic | 1 | 2013 | 1779 | 0.060 |
Why?
|
Gestational Age | 3 | 2019 | 3577 | 0.060 |
Why?
|
Longitudinal Studies | 5 | 2024 | 14605 | 0.060 |
Why?
|
MicroRNAs | 1 | 2021 | 3816 | 0.060 |
Why?
|
Mental Health Services | 1 | 2016 | 1730 | 0.060 |
Why?
|
Denmark | 2 | 2020 | 771 | 0.060 |
Why?
|
Models, Biological | 2 | 2013 | 9469 | 0.060 |
Why?
|
Otitis Media | 1 | 2007 | 286 | 0.060 |
Why?
|
HIV-1 | 1 | 2022 | 6863 | 0.060 |
Why?
|
Sweetening Agents | 1 | 2007 | 290 | 0.060 |
Why?
|
Cross-Sectional Studies | 5 | 2021 | 26125 | 0.060 |
Why?
|
Algorithms | 4 | 2013 | 14031 | 0.060 |
Why?
|
Substance-Related Disorders | 2 | 2013 | 4420 | 0.060 |
Why?
|
New York | 2 | 2018 | 874 | 0.060 |
Why?
|
Medication Adherence | 2 | 2013 | 2176 | 0.060 |
Why?
|
Medicare | 1 | 2021 | 6770 | 0.050 |
Why?
|
Confidentiality | 1 | 2007 | 609 | 0.050 |
Why?
|
Geography | 1 | 2005 | 656 | 0.050 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2004 | 386 | 0.050 |
Why?
|
Odds Ratio | 3 | 2015 | 9646 | 0.050 |
Why?
|
Sepsis | 1 | 2017 | 2585 | 0.050 |
Why?
|
Appendicitis | 1 | 2009 | 675 | 0.050 |
Why?
|
Lymphatic Metastasis | 1 | 2010 | 2915 | 0.050 |
Why?
|
Dementia | 1 | 2016 | 2686 | 0.050 |
Why?
|
Aging | 2 | 2012 | 8708 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3889 | 0.050 |
Why?
|
Sensitivity and Specificity | 6 | 2013 | 14666 | 0.050 |
Why?
|
Hospitals, Community | 1 | 2024 | 365 | 0.050 |
Why?
|
Interleukin-12 | 1 | 2004 | 584 | 0.050 |
Why?
|
Brain Ischemia | 1 | 2015 | 3049 | 0.050 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2010 | 2010 | 0.050 |
Why?
|
Clinical Clerkship | 1 | 2007 | 564 | 0.050 |
Why?
|
Radiation Oncology | 1 | 2007 | 563 | 0.050 |
Why?
|
Japan | 2 | 2020 | 1378 | 0.050 |
Why?
|
Mammography | 2 | 2010 | 2430 | 0.050 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2013 | 2518 | 0.050 |
Why?
|
Interleukin-13 | 1 | 2023 | 392 | 0.050 |
Why?
|
Ecchymosis | 1 | 2020 | 32 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 1 | 2016 | 3627 | 0.050 |
Why?
|
Antibodies, Viral | 2 | 2022 | 3156 | 0.050 |
Why?
|
Osteoarthritis, Knee | 1 | 2011 | 1234 | 0.050 |
Why?
|
Deductibles and Coinsurance | 1 | 2023 | 316 | 0.040 |
Why?
|
Educational Measurement | 1 | 2007 | 1254 | 0.040 |
Why?
|
Bulgaria | 1 | 2020 | 17 | 0.040 |
Why?
|
Leukocyte Count | 1 | 2024 | 1596 | 0.040 |
Why?
|
Radiopharmaceuticals | 1 | 2010 | 2651 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2015 | 15266 | 0.040 |
Why?
|
Nursing Care | 1 | 2020 | 65 | 0.040 |
Why?
|
Animals | 6 | 2024 | 168459 | 0.040 |
Why?
|
Contrast Media | 2 | 2010 | 5311 | 0.040 |
Why?
|
Mycobacterium bovis | 1 | 2020 | 147 | 0.040 |
Why?
|
Adolescent Behavior | 1 | 2008 | 1190 | 0.040 |
Why?
|
Diglycerides | 1 | 2019 | 177 | 0.040 |
Why?
|
Lacerations | 1 | 2020 | 147 | 0.040 |
Why?
|
Georgia | 1 | 2018 | 185 | 0.040 |
Why?
|
Pregnancy | 4 | 2023 | 29874 | 0.040 |
Why?
|
Models, Theoretical | 1 | 2010 | 3575 | 0.040 |
Why?
|
Proportional Hazards Models | 4 | 2016 | 12463 | 0.040 |
Why?
|
Fracture Fixation | 1 | 2020 | 366 | 0.040 |
Why?
|
Imidazoles | 1 | 2024 | 1180 | 0.040 |
Why?
|
Immunization | 1 | 2022 | 1228 | 0.040 |
Why?
|
Risk | 2 | 2011 | 9610 | 0.040 |
Why?
|
Recombinant Proteins | 2 | 2018 | 6534 | 0.040 |
Why?
|
Staphylococcus epidermidis | 1 | 2018 | 123 | 0.040 |
Why?
|
Venous Thrombosis | 1 | 2007 | 1303 | 0.040 |
Why?
|
High-Throughput Screening Assays | 1 | 2023 | 934 | 0.040 |
Why?
|
Rosaniline Dyes | 1 | 2017 | 50 | 0.040 |
Why?
|
Body Height | 1 | 2023 | 1570 | 0.040 |
Why?
|
Documentation | 1 | 2023 | 897 | 0.040 |
Why?
|
Immunomodulation | 1 | 2021 | 549 | 0.040 |
Why?
|
Interleukin-17 | 1 | 2023 | 912 | 0.040 |
Why?
|
Mental Health | 3 | 2020 | 3250 | 0.040 |
Why?
|
Head and Neck Neoplasms | 1 | 2011 | 2895 | 0.030 |
Why?
|
Salmonella | 1 | 2017 | 125 | 0.030 |
Why?
|
Critical Pathways | 1 | 2020 | 474 | 0.030 |
Why?
|
Enzyme Assays | 1 | 2017 | 104 | 0.030 |
Why?
|
Drug Discovery | 1 | 2024 | 1051 | 0.030 |
Why?
|
Thyroid Function Tests | 1 | 2017 | 288 | 0.030 |
Why?
|
Risk Assessment | 5 | 2016 | 23995 | 0.030 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2018 | 353 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2013 | 22176 | 0.030 |
Why?
|
Liver | 1 | 2011 | 7529 | 0.030 |
Why?
|
Suture Techniques | 1 | 2020 | 769 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2009 | 4063 | 0.030 |
Why?
|
Parturition | 1 | 2019 | 445 | 0.030 |
Why?
|
Area Under Curve | 2 | 2010 | 1638 | 0.030 |
Why?
|
NF-kappa B | 1 | 2024 | 2490 | 0.030 |
Why?
|
Computational Biology | 1 | 2007 | 3518 | 0.030 |
Why?
|
Systems Biology | 1 | 2019 | 481 | 0.030 |
Why?
|
Interdisciplinary Studies | 1 | 2015 | 86 | 0.030 |
Why?
|
HIV | 1 | 2022 | 1582 | 0.030 |
Why?
|
Candida albicans | 1 | 2018 | 372 | 0.030 |
Why?
|
Klebsiella pneumoniae | 1 | 2017 | 250 | 0.030 |
Why?
|
Alcohol Drinking | 1 | 2008 | 4028 | 0.030 |
Why?
|
Smoking | 2 | 2011 | 9053 | 0.030 |
Why?
|
Comorbidity | 3 | 2014 | 10508 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2021 | 1937 | 0.030 |
Why?
|
Pregnant Women | 1 | 2019 | 566 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2011 | 36426 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2021 | 1359 | 0.030 |
Why?
|
Students, Medical | 1 | 2007 | 1936 | 0.030 |
Why?
|
Age Distribution | 2 | 2012 | 2880 | 0.030 |
Why?
|
Brain | 2 | 2012 | 27112 | 0.030 |
Why?
|
Sex Distribution | 2 | 2010 | 2281 | 0.030 |
Why?
|
Treatment Outcome | 7 | 2015 | 64680 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2019 | 1870 | 0.030 |
Why?
|
Oligopeptides | 1 | 2019 | 1187 | 0.030 |
Why?
|
Mental Disorders | 1 | 2014 | 6845 | 0.030 |
Why?
|
Women's Health | 2 | 2015 | 2065 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2004 | 4243 | 0.030 |
Why?
|
Anxiety | 2 | 2021 | 4573 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2024 | 5869 | 0.030 |
Why?
|
New England | 1 | 2016 | 1054 | 0.030 |
Why?
|
Congenital Abnormalities | 1 | 2018 | 709 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2022 | 1902 | 0.030 |
Why?
|
Diagnosis, Differential | 3 | 2018 | 12974 | 0.030 |
Why?
|
Phosphates | 1 | 2017 | 770 | 0.030 |
Why?
|
Anti-Retroviral Agents | 1 | 2023 | 1784 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2024 | 5247 | 0.030 |
Why?
|
Thyrotropin | 1 | 2017 | 834 | 0.030 |
Why?
|
Thyroxine | 1 | 2017 | 666 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2023 | 3208 | 0.030 |
Why?
|
Normal Distribution | 1 | 2013 | 272 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2013 | 7879 | 0.030 |
Why?
|
India | 1 | 2020 | 2348 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2021 | 1802 | 0.030 |
Why?
|
Public Health | 2 | 2018 | 2669 | 0.030 |
Why?
|
Colombia | 1 | 2013 | 282 | 0.030 |
Why?
|
Viral Load | 1 | 2022 | 3332 | 0.030 |
Why?
|
Delphi Technique | 1 | 2016 | 846 | 0.030 |
Why?
|
Mass Screening | 1 | 2008 | 5428 | 0.030 |
Why?
|
Clinical Coding | 1 | 2014 | 181 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2013 | 11460 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2019 | 18965 | 0.030 |
Why?
|
Blood | 1 | 2015 | 596 | 0.030 |
Why?
|
Diagnosis-Related Groups | 1 | 2014 | 449 | 0.030 |
Why?
|
Isoenzymes | 1 | 2017 | 1687 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 2 | 2021 | 3205 | 0.030 |
Why?
|
Dicarbethoxydihydrocollidine | 1 | 2011 | 3 | 0.030 |
Why?
|
Mothers | 1 | 2023 | 2198 | 0.020 |
Why?
|
New Mexico | 1 | 2012 | 83 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2022 | 1943 | 0.020 |
Why?
|
Residence Characteristics | 2 | 2014 | 2093 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2023 | 4352 | 0.020 |
Why?
|
Perfusion Imaging | 1 | 2013 | 196 | 0.020 |
Why?
|
Mice | 4 | 2024 | 81525 | 0.020 |
Why?
|
Libido | 1 | 2011 | 119 | 0.020 |
Why?
|
Polypharmacy | 1 | 2014 | 306 | 0.020 |
Why?
|
Biomedical Research | 1 | 2007 | 3429 | 0.020 |
Why?
|
Coitus | 1 | 2011 | 132 | 0.020 |
Why?
|
Veterans | 2 | 2016 | 2647 | 0.020 |
Why?
|
Exercise | 2 | 2020 | 5890 | 0.020 |
Why?
|
Serum Albumin | 1 | 2014 | 672 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3802 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12059 | 0.020 |
Why?
|
Heart Failure | 1 | 2015 | 11669 | 0.020 |
Why?
|
Patient Selection | 1 | 2023 | 4244 | 0.020 |
Why?
|
Survival Analysis | 2 | 2015 | 10090 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2017 | 2329 | 0.020 |
Why?
|
Sample Size | 1 | 2013 | 841 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2023 | 3745 | 0.020 |
Why?
|
Thyroid Gland | 1 | 2017 | 1168 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2021 | 5486 | 0.020 |
Why?
|
Palpation | 1 | 2010 | 166 | 0.020 |
Why?
|
Pharmacy Service, Hospital | 1 | 2011 | 134 | 0.020 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2017 | 1017 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2018 | 1458 | 0.020 |
Why?
|
Blood Volume | 1 | 2011 | 547 | 0.020 |
Why?
|
Bacteria | 1 | 2020 | 2199 | 0.020 |
Why?
|
Radiography | 1 | 2020 | 6965 | 0.020 |
Why?
|
Metabolomics | 1 | 2019 | 1659 | 0.020 |
Why?
|
Prognosis | 3 | 2015 | 29625 | 0.020 |
Why?
|
Stress, Psychological | 2 | 2018 | 4481 | 0.020 |
Why?
|
Propensity Score | 1 | 2016 | 1913 | 0.020 |
Why?
|
Depression | 2 | 2021 | 8124 | 0.020 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2011 | 395 | 0.020 |
Why?
|
Tomography, Spiral Computed | 1 | 2010 | 273 | 0.020 |
Why?
|
Medical Records | 1 | 2014 | 1408 | 0.020 |
Why?
|
Fractures, Bone | 1 | 2020 | 2046 | 0.020 |
Why?
|
Echo-Planar Imaging | 1 | 2012 | 663 | 0.020 |
Why?
|
Observer Variation | 1 | 2014 | 2606 | 0.020 |
Why?
|
Social Support | 1 | 2018 | 2171 | 0.020 |
Why?
|
Absenteeism | 1 | 2009 | 247 | 0.020 |
Why?
|
Macroglossia | 1 | 2007 | 12 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1505 | 0.020 |
Why?
|
Submandibular Gland Diseases | 1 | 2007 | 22 | 0.020 |
Why?
|
Submandibular Gland | 1 | 2007 | 87 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2011 | 1496 | 0.020 |
Why?
|
Acute Disease | 2 | 2009 | 7237 | 0.020 |
Why?
|
Axilla | 1 | 2010 | 624 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2009 | 1379 | 0.020 |
Why?
|
Models, Economic | 1 | 2011 | 716 | 0.020 |
Why?
|
Tomography, Emission-Computed | 1 | 2010 | 1122 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 3249 | 0.020 |
Why?
|
Vitamin K | 1 | 2009 | 318 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2013 | 2358 | 0.020 |
Why?
|
SEER Program | 1 | 2011 | 1450 | 0.020 |
Why?
|
Radiography, Abdominal | 1 | 2009 | 534 | 0.020 |
Why?
|
Cicatrix | 1 | 2012 | 798 | 0.020 |
Why?
|
Brazil | 1 | 2010 | 1230 | 0.020 |
Why?
|
Prejudice | 1 | 2010 | 570 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2008 | 957 | 0.020 |
Why?
|
Reference Standards | 1 | 2009 | 1003 | 0.020 |
Why?
|
Joints | 1 | 2007 | 322 | 0.020 |
Why?
|
Arousal | 1 | 2011 | 1166 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2011 | 1668 | 0.020 |
Why?
|
Asthma | 1 | 2004 | 6234 | 0.020 |
Why?
|
Social Environment | 1 | 2010 | 1020 | 0.020 |
Why?
|
Tumor Burden | 1 | 2011 | 1893 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2012 | 9000 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 4853 | 0.020 |
Why?
|
Logistic Models | 2 | 2010 | 13255 | 0.020 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2011 | 801 | 0.020 |
Why?
|
Interleukin-12 Subunit p40 | 1 | 2004 | 57 | 0.010 |
Why?
|
Biopsy | 1 | 2016 | 6766 | 0.010 |
Why?
|
Tongue | 1 | 2007 | 403 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2015 | 2629 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2013 | 22169 | 0.010 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2007 | 303 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2014 | 6019 | 0.010 |
Why?
|
Life Style | 1 | 2015 | 3917 | 0.010 |
Why?
|
Gynecology | 1 | 2009 | 526 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5492 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2009 | 1386 | 0.010 |
Why?
|
Abdominal Pain | 1 | 2009 | 1071 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2011 | 6228 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9420 | 0.010 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2009 | 1222 | 0.010 |
Why?
|
Inheritance Patterns | 1 | 2004 | 341 | 0.010 |
Why?
|
Alcoholism | 1 | 2013 | 1973 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9326 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2010 | 3595 | 0.010 |
Why?
|
Patient Admission | 1 | 2009 | 1367 | 0.010 |
Why?
|
Heart Valve Diseases | 1 | 2009 | 1027 | 0.010 |
Why?
|
ROC Curve | 1 | 2009 | 3579 | 0.010 |
Why?
|
Causality | 1 | 2008 | 1242 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2007 | 2927 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6484 | 0.010 |
Why?
|
Schools | 1 | 2009 | 1489 | 0.010 |
Why?
|
Clinical Competence | 1 | 2016 | 4792 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2014 | 7827 | 0.010 |
Why?
|
Students | 1 | 2009 | 1741 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2017 | 10194 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 2004 | 1998 | 0.010 |
Why?
|
Haplotypes | 1 | 2004 | 2713 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10766 | 0.010 |
Why?
|
Diet | 1 | 2015 | 8075 | 0.010 |
Why?
|
Bone and Bones | 1 | 2007 | 2568 | 0.010 |
Why?
|
Pedigree | 1 | 2004 | 4542 | 0.010 |
Why?
|
Sex Factors | 1 | 2009 | 10552 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15500 | 0.010 |
Why?
|
Inflammation | 1 | 2011 | 10773 | 0.010 |
Why?
|
Genotype | 1 | 2004 | 12990 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2007 | 5146 | 0.010 |
Why?
|